全球抗栓袜市场

预计 2030 年全球抗栓袜市场规模将达 9.738 亿美元

全球抗栓塞袜市场规模预计在2024年为7.707亿美元，到2030年将达到9.738亿美元，在2024-2030年的分析期间内，复合年增长率为4.0%。小腿长度的抗栓塞袜是本报告分析的细分市场之一，预计其复合年增长率为4.8%，到分析期结束时将达到6.142亿美元。大腿长度的抗栓塞袜细分市场在分析期间的复合年增长率预计为2.7%。

美国市场预计将达到 2.1 亿美元，而中国市场预计将以 7.5% 的复合年增长率成长

美国抗栓袜市场规模预计2024年达到2.1亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到1.994亿美元，在分析期间（2024-2030年）的复合年增长率为7.5%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.6%和3.1%。在欧洲，预计德国市场的复合年增长率为2.3%。

全球抗栓塞袜市场－主要趋势与驱动因素摘要

为什么抗栓塞袜成为术后和卧床患者照护的重要一环？

抗栓塞袜已成为预防静脉血栓栓塞症(VTE) 的重要工具，尤其适用于接受手术或卧床不起的患者。这些专用袜旨在对下肢施加渐进式压力，透过将静脉血推回心臟来促进血液循环，防止血液淤滞（血栓形成的主要原因）。这些袜子的作用在医院环境中尤其重要，因为在大型手术、创伤和长期復原期间的不动会显着增加深层静脉栓塞症(DVT) 和肺动脉栓塞(PE) 的风险。各学科的医疗保健提供者现在都将抗栓塞袜视为高风险患者的标准护理，通常与抗凝血治疗结合使用以减少併发症。术后患者，尤其是从整形外科、腹部和心血管手术中恢復的患者，可能在几天甚至几週内活动受限，因此使用抗栓塞袜将大有裨益。此外，它们也被广泛推荐用于加护病房(ICU)、老年病房和復健中心的病人。随着医院越来越注重患者的治疗效果和安全，降低深部静脉栓塞 (DVT) 等医院内感染的发生率已成为当务之急，这促使抗栓袜得到广泛应用。抗栓袜的成本效益、易用性和非侵入性使其成为住院和门诊病人的理想选择。在许多情况下，这些袜的使用是由机构通讯协定和/或医疗保险提供者强制要求的，这进一步巩固了它们在现代预防医学中的作用。

哪些医疗和材料创新使抗栓塞袜更有效？

医用纺织品和压力技术的最新进展显着提高了抗栓袜的舒适度、功效和依从性。过去，不适感、尺寸不合适以及穿脱困难限制了患者的依从性。现今的袜子采用透气、低致敏性和抗菌材料製成，可减少皮肤刺激，并可在不影响卫生的情况下延长穿着时间。渐进式压力技术也得到了发展，可以精确控制压力等级，通常在脚踝处压力最高，并逐渐向大腿方向降低，以优化静脉回流，同时不会限制活动或损伤组织。无缝针织和人体工学设计改善了人体结构贴合度，提高了治疗效果和穿着舒适度。有些袜子现在采用了能够调节体温的智慧纤维，这对于在不同气候条件下长期穿着尤其有益。此外，颜色编码的尺寸系统和增强的弹性简化了产品选择，并降低了因使用不当而导致的风险。 3D人体扫描仪和行动应用程式等数位工具正被用于辅助精准试穿，尤其是在门诊病人中。同时，嵌入感测器的弹性袜的研究也正在进行中，这种弹性袜可以即时监测静脉压力和运动，并有可能将这些服装转化为诊断工具。这些技术创新正在提高抗栓塞弹性袜的临床和功能标准，确保患者更顺畅地服药并改善治疗效果，从而为更广泛的医疗保健场景开闢应用前景。

全球人口趋势和医疗保健如何推动抗栓塞袜市场？

宏观人口结构的变化和不断发展的医疗保健服务模式正在塑造全球抗栓塞袜市场。与老龄化相关的静脉功能不全、行动不便和外科手术的盛行率显着升高，尤其是在北美、欧洲和亚洲部分地区。老年人更容易感染静脉血栓栓塞症 (VTE)，医生通常会将抗栓塞袜等预防措施作为日常护理的一部分。此外，肥胖、心血管疾病和糖尿病等慢性疾病负担的增加进一步增加了血栓风险，需要采取主动干预措施。同时，择期手术（尤其是膝关节和髋关节置换术等整形外科手术）的增多，使得住院和出院后对这些产品的需求持续稳定增长。向门诊关节重建和当日出院模式的转变推动了对患者管理的预防保健的需求，而抗栓塞袜在这些通讯协定中发挥着核心作用。随着医疗基础设施的改善和静脉血栓栓塞 (VTE) 预防意识的提升，新兴市场也在推动市场发展。公共卫生宣传活动和机构强制要求不断提升深部静脉血栓 (DVT) 预防的重要性，尤其是在外科和长期照护机构。此外，保险报销和综合护理计划进一步鼓励使用经济高效的非药物预防方法。同时，线上零售通路和电子药局也让寻求居家医疗解决方案的消费者更容易获得弹性袜，并鼓励其在临床治疗之外的使用。这些人口结构和结构性变化共同作用，正在为全球各级护理机构带来持续的抗栓弹性袜需求。

全球越来越多采用抗栓塞袜的主要驱动因素是什么？

抗栓塞袜市场的成长受到多种重要因素的驱动，这些因素源自于临床需求、医疗政策、技术进步和消费行为。其中最重要的因素之一是静脉血栓栓塞（VTE）发病率的上升，尤其是在住院患者、术后患者和无法活动的患者中。监管机构和专业医学协会已发布指南，建议将压迫疗法作为标准预防措施，使其在医学上得到合理认可和机构支持。实证医学的采用使得医院广泛将抗栓塞袜纳入其手术恢復通讯协定中，旨在减少併发症、再入院率和相关的医疗成本。另一个主要驱动因素是纺织工程的持续进步，这使得製造商能够生产出不仅更有效而且更易于穿着的袜子，从而提高了患者的依从性和满意度。远端医疗和远距患者管理的日益普及也起到了一定作用，临床医生会向在家休养的患者推荐压力服，尤其是在整形外科和心血管手术后。此外，日益增强的健康意识和积极主动的健康行为促使消费者即使没有直接处方笺也会购买压力袜等预防性医疗产品。产品分销管道急剧扩张，如今可透过药局、线上平台、医疗供应商甚至健康相关零售商购买。医疗保健提供者与製造商之间的策略伙伴关係，以及针对患者和临床医生的教育计划，进一步推动了其普及。这些因素，加上对早期疗育、预防医学和非侵入性治疗方案的重视，巩固了抗栓袜作为全球现代医疗保健系统基本组成部分的地位。

部分

产品（小腿长度栓塞袜、大腿长度栓塞袜）；人口统计资料（男性、女性）；最终用途（门诊病人最终用途、术后患者最终用途、孕妇最终用途、其他最终用途）

调查企业范例（共34家企业）

• 3M Company
• B. Braun Melsungen AG
• BSN Medical GmbH
• Cardinal Health Inc.
• Covidien（Medtronic）
• Essity AB
• Halyard Health Inc.
• Kendall（Covidien）
• Lohmann & Rauscher GmbH
• Medline Industries, Inc.
• Molnlycke Health Care AB
• Paul Hartmann AG
• Prestige Brands Holdings Inc.
• Sanko Medical Co., Ltd.
• Sigvaris AG
• Smith & Nephew plc
• Solidea Srl
• Thermo Fisher Scientific Inc.
• Thuasne Group
• Unomedical（a part of Coloplast）

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自全球领域专家的精选内容库，其中包括视频记录、博客、搜寻引擎研究以及大量公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Anti-Embolism Stockings Market to Reach US$973.8 Million by 2030

The global market for Anti-Embolism Stockings estimated at US$770.7 Million in the year 2024, is expected to reach US$973.8 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Calf-Length Anti-Embolism Stockings, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$614.2 Million by the end of the analysis period. Growth in the Thigh-Length Anti-Embolism Stockings segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$210.0 Million While China is Forecast to Grow at 7.5% CAGR

The Anti-Embolism Stockings market in the U.S. is estimated at US$210.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$199.4 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Anti-Embolism Stockings Market - Key Trends & Drivers Summarized

Why Are Anti-Embolism Stockings Becoming a Critical Component of Post-Surgical and Bedridden Patient Care?

Anti-embolism stockings have emerged as a crucial tool in the prevention of venous thromboembolism (VTE), particularly for patients undergoing surgery or confined to bed rest. Designed to apply graduated pressure to the lower limbs, these specialized stockings enhance blood circulation by pushing venous blood back toward the heart, thereby preventing stasis-a key contributor to clot formation. Their role has become especially vital in hospital environments where immobility, whether due to major surgery, trauma, or prolonged recovery, significantly elevates the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Healthcare providers across disciplines now consider anti-embolism stockings a standard of care for at-risk patients, often using them in combination with anticoagulant therapies to reduce complications. Postoperative patients, especially those recovering from orthopedic, abdominal, or cardiovascular procedures, benefit enormously from their use, as movement may be restricted for days or even weeks. Moreover, they are widely recommended for patients in intensive care units (ICUs), geriatric wards, and rehabilitation centers. As hospitals increasingly focus on patient outcomes and safety metrics, reducing the incidence of hospital-acquired conditions like DVT has become a top priority-thus driving the widespread use of anti-embolism stockings. Their cost-effectiveness, ease of application, and non-invasive nature make them an attractive option for both inpatient and outpatient settings. In many cases, the use of these stockings is mandated by institutional protocols and health insurance providers, further cementing their role in modern preventive medicine.

What Medical and Material Innovations Are Enhancing the Efficacy of Anti-Embolism Stockings?

Recent advances in medical textiles and compression technology are significantly improving the comfort, effectiveness, and compliance associated with anti-embolism stockings. Historically, patient adherence was limited due to discomfort, improper sizing, or difficulty in donning the stockings-issues that have now been addressed through more sophisticated designs and materials. Today’s stockings are made with breathable, hypoallergenic, and antimicrobial fabrics that reduce skin irritation and allow for prolonged wear without compromising hygiene. Graduated compression technology has also evolved, allowing for precise control over pressure levels-typically highest at the ankle and gradually decreasing toward the thigh-to optimize venous return without constricting movement or causing tissue damage. Seamless knitting techniques and ergonomic designs ensure a better anatomical fit, which not only improves therapeutic outcomes but also enhances user comfort. Some stockings now incorporate smart fibers capable of temperature regulation, which is particularly beneficial for long-term wear in varied climates. In addition, color-coded sizing systems and improved elasticity have simplified product selection and reduced the risk of improper usage. Digital tools such as 3D body scanners and mobile apps are being used to assist with accurate fitting, especially in outpatient scenarios. Meanwhile, research is ongoing into sensor-embedded stockings that can monitor venous pressure or movement in real-time, potentially transforming these garments into diagnostic tools as well. These technological innovations are raising the clinical and functional standards of anti-embolism stockings, ensuring better patient adherence, improved outcomes, and expanding their application across a wider spectrum of medical scenarios.

How Are Global Demographic Trends and Healthcare Practices Expanding the Market for Anti-Embolism Stockings?

The global market for anti-embolism stockings is being shaped by macro-level demographic shifts and evolving healthcare delivery models. A key factor is the aging global population, particularly in regions like North America, Europe, and parts of Asia, where the prevalence of age-related venous insufficiency, limited mobility, and surgical interventions is significantly higher. Older adults are more susceptible to VTE, and preventive measures like anti-embolism stockings are increasingly prescribed as part of routine care. Additionally, the growing burden of chronic diseases such as obesity, cardiovascular conditions, and diabetes further increases the risk of blood clots, necessitating proactive interventions. At the same time, the rising frequency of elective surgeries-particularly orthopedic procedures such as knee and hip replacements-has created a steady demand for these products in both hospital and post-discharge settings. The shift toward outpatient surgery and same-day discharge models has heightened the need for patient-managed preventive care, with anti-embolism stockings playing a central role in these protocols. Developing nations are also contributing to market growth as healthcare infrastructure improves and awareness of VTE prevention increases. Public health campaigns and institutional mandates are reinforcing the importance of DVT prophylaxis, especially in surgical and long-term care environments. Insurance reimbursement and bundled care initiatives are further incentivizing the use of cost-effective, non-pharmacological preventive measures. In parallel, online retail channels and e-pharmacies are making these stockings more accessible to consumers seeking at-home medical solutions, supporting their use beyond the clinical setting. Collectively, these demographic and structural shifts are creating sustained, global demand for anti-embolism stockings across multiple levels of care.

What Are the Core Drivers Behind the Rising Adoption of Anti-Embolism Stockings Worldwide?

The growth in the anti-embolism stockings market is driven by several compelling factors grounded in clinical demand, healthcare policy, technological improvement, and consumer behavior. One of the most critical drivers is the increasing incidence of VTE, particularly among hospitalized, post-surgical, and immobile patients-a demographic that continues to expand with rising hospitalization rates and longer life expectancy. Regulatory agencies and professional medical associations have issued guidelines recommending the use of compression therapy as a standard preventive measure, giving the category both medical legitimacy and institutional support. The adoption of evidence-based medicine has led to widespread incorporation of anti-embolism stockings in surgical recovery protocols, with hospitals aiming to reduce complications, readmissions, and associated healthcare costs. Another major driver is the continuous advancement in textile engineering, allowing manufacturers to create stockings that are not only more effective but also more wearable-leading to better patient compliance and satisfaction. The increasing popularity of telehealth and remote patient management is also contributing, as clinicians recommend compression wear for patients recovering at home, especially after orthopedic or cardiovascular procedures. Moreover, the rise in health awareness and proactive wellness behaviors has encouraged consumers to invest in preventive health products like compression stockings even without a direct prescription. Distribution has expanded dramatically, with products now available via pharmacies, online platforms, medical suppliers, and even wellness retailers. Strategic partnerships between healthcare providers and manufacturers, along with educational initiatives aimed at both patients and clinicians, are further driving adoption. These factors-combined with a focus on early intervention, preventive care, and non-invasive treatment options-are cementing the role of anti-embolism stockings as a fundamental component of modern healthcare systems around the world.

SCOPE OF STUDY:

The report analyzes the Anti-Embolism Stockings market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Calf-Length Anti-Embolism Stockings, Thigh-Length Anti-Embolism Stockings); Demography (Men, Women); End-Use (Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• 3M Company
• B. Braun Melsungen AG
• BSN Medical GmbH
• Cardinal Health Inc.
• Covidien (Medtronic)
• Essity AB
• Halyard Health Inc.
• Kendall (Covidien)
• Lohmann & Rauscher GmbH
• Medline Industries, Inc.
• Molnlycke Health Care AB
• Paul Hartmann AG
• Prestige Brands Holdings Inc.
• Sanko Medical Co., Ltd.
• Sigvaris AG
• Smith & Nephew plc
• Solidea S.r.l.
• Thermo Fisher Scientific Inc.
• Thuasne Group
• Unomedical (a part of Coloplast)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Anti-Embolism Stockings - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Surgical and Postoperative Complication Awareness Throws the Spotlight on Anti-Embolism Stockings
  • Use in DVT Prevention Among Hospitalized and Immobile Patients Drives Demand
  • OEMs Offering Graduated Compression Stockings With Improved Comfort Enhance Wearability
  • Expansion of Preventive Protocols in Orthopedic, Cardiac, and Cancer Surgeries Spurs Market Uptake
  • Rising Elderly and Postpartum Populations Support Broad-Based Prophylactic Use
  • OEMs Emphasizing Latex-Free, Breathable, and Skin-Friendly Fabrics Improve Patient Compliance
  • Growth in Long-Distance Travel and Air Travel Health Awareness Supports Consumer-Grade Adoption
  • Integration With Smart Monitoring Wearables for Circulation Adds Technological Edge
  • Use in Homecare and Outpatient Recovery Strengthens Demand for Over-the-Counter Stockings
  • OEMs Offering Size-Variant and Adjustable Designs Enhance Personalization and Fit
  • Increased Emphasis on Fall Prevention and Mobility Support Expands Multifunctional Use
  • Growing Institutional Adoption in ICU and Rehabilitation Centers Drives Bulk Procurement
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Anti-Embolism Stockings Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Calf-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Calf-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Calf-Length Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Thigh-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Thigh-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Thigh-Length Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Men by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Women by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Post-operative Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Post-operative Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Post-operative Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pregnant Women End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pregnant Women End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pregnant Women End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Anti-Embolism Stockings by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Anti-Embolism Stockings by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Anti-Embolism Stockings by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Anti-Embolism Stockings by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION